AI case study

Tangram TherapeuticsDrug discovery

Target assessments took a full quarter. Now, AI agents synthesize 1,000+ datasets to finish in hours.

Published|1 month ago

Key results

Assessment Speed
up to 50x
Data Processing Volume
300x

Result highlights

Unlock 2 result highlights

The story

Context

A UK-based biotech company merging biology and computation to accelerate the discovery of RNA interference (RNAi) medicines for diseases with significant unmet needs.

Challenge

Traditional drug discovery timelines were prohibitively slow, with document processing taking weeks and target-indication assessments requiring a...

Solution
Unlock full story

Quotes

Unlock 2 more quotes

The company

Tangram Therapeutics logo

Tangram Therapeutics

tangramtx.com

Biotech platform for computational drug discovery and RNAi medicines.

IndustryPharmaceuticals & Biotech
LocationLondon, United Kingdom
Employees11-50
Founded2021

The vendor

Amazon Web Services (AWS) logo

Amazon Web Services (AWS)

aws.amazon.com

Cloud computing platform and on-demand infrastructure services.

IndustryTechnology
LocationSeattle, WA, USA
Employees100K+
Founded2006

Similar Case Studies

Related implementations across industries and use cases

57 AI case studies in Scientific Discovery

136 AI case studies in Pharmaceuticals & Biotech

1,413 AI case studies in Product Engineering